Shares

15 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2022

Feb 14, 2023

BUY
$204.38 - $296.82 $73.8 Million - $107 Million
361,220 New
361,220 $74.3 Million
Q3 2022

Nov 14, 2022

BUY
$195.21 - $310.53 $5.03 Million - $8 Million
25,770 Added 7.51%
368,713 $103 Million
Q2 2022

Aug 15, 2022

BUY
$115.91 - $214.48 $22.2 Million - $41.1 Million
191,705 Added 126.76%
342,943 $65.6 Million
Q1 2022

May 11, 2022

BUY
$127.96 - $207.36 $482,537 - $781,954
3,771 Added 2.56%
151,238 $31.4 Million
Q4 2021

Feb 11, 2022

SELL
$165.13 - $241.83 $118,067 - $172,908
-715 Reduced 0.48%
147,467 $26.3 Million
Q3 2021

Nov 12, 2021

BUY
$163.99 - $235.57 $1.76 Million - $2.53 Million
10,721 Added 7.8%
148,182 $30.5 Million
Q2 2021

Aug 11, 2021

BUY
$131.45 - $201.49 $3.16 Million - $4.84 Million
24,025 Added 21.18%
137,461 $26.1 Million
Q1 2021

May 13, 2021

SELL
$92.73 - $142.05 $1.05 Million - $1.61 Million
-11,367 Reduced 9.11%
113,436 $14.8 Million
Q4 2020

Feb 09, 2021

BUY
$67.44 - $103.72 $49,231 - $75,715
730 Added 0.59%
124,803 $12.9 Million
Q3 2020

Nov 12, 2020

BUY
$42.79 - $75.8 $1.02 Million - $1.8 Million
23,729 Added 23.65%
124,073 $9.4 Million
Q2 2020

Aug 12, 2020

BUY
$27.25 - $47.53 $449,870 - $784,672
16,509 Added 19.69%
100,344 $4.75 Million
Q1 2020

May 06, 2020

BUY
$23.16 - $47.74 $233,777 - $481,887
10,094 Added 13.69%
83,835 $2.78 Million
Q4 2019

Feb 14, 2020

BUY
$29.4 - $44.98 $1.54 Million - $2.35 Million
52,293 Added 243.81%
73,741 $3.24 Million
Q3 2019

Nov 07, 2019

SELL
$29.71 - $55.23 $155,413 - $288,908
-5,231 Reduced 19.61%
21,448 $641,000
Q2 2019

Aug 12, 2019

BUY
$29.73 - $66.02 $793,166 - $1.76 Million
26,679 New
26,679 $1.52 Million

Others Institutions Holding SWAV

About Shockwave Medical, Inc.


  • Ticker SWAV
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 35,927,100
  • Description
  • ShockWave Medical, Inc., a medical device company, engages in developing and commercializing intravascular lithotripsy technology for the treatment of calcified plaque in patients with peripheral vascular, coronary vascular, and heart valve diseases worldwide. The company offers M5 catheters for treating above-the-knee peripheral artery disease ...
More about SWAV
Track This Portfolio

Track Bank Of New York Mellon Corp Portfolio

Follow Bank Of New York Mellon Corp and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Bank Of New York Mellon Corp, based on Form 13F filings with the SEC.

News

Stay updated on Bank Of New York Mellon Corp with notifications on news.